Newsletter | November 26, 2025

11.26.25 -- The Quest For A Type 1 Diabetes Cure Without Immunosuppression

SPONSOR

Clinical trials drive medical progress, and SCOPE brings the community together to advance them. Returning February 2–5, 2026, in Orlando, SCOPE builds on 2025’s record 4,500+ attendees, 630 speakers, and 300 exhibitors. The 2026 program features 30 tracks, new additions in Market Access, Safety, and Therapeutic Areas, major awards, and expanded coverage of AI, patient-centric design, site engagement, and trial operations. SCOPE unites global leaders shaping the future of clinical research. www.SCOPEsummit.com

FEATURED ARTICLE

BoB In South Florida: Anthony Japour, M.D., iTolerance

Anthony Japour, M.D., CEO at iTolerance, talks about his work as a physician treating infectious diseases, his CEO role in diagnostics at the height of the COVID-19 pandemic, what he learned working as a medical director at a large CRO, and iTolerance's work toward a cure for Type 1 diabetes that doesn't require chronic immunosuppression.

INDUSTRY INSIGHTS

Shifting Left In Software Development: Reducing Risk Through Early Testing

In today’s development landscape, where speed and resilience must go hand in hand, adopting a “Shift Left” mindset transforms testing from a bottleneck into a catalyst for innovation.

Building A Strong Safety Culture In The Biopharmaceutical Industry

Fostering a strong safety culture — rooted in accountability, collaboration, and proactive risk management — can drive operational excellence and long-term success in biopharmaceuticals.

It's Never Too Late To Intensify: Upstream Process Intensification

Early upstream intensification, flexible facility design, and smart technology choices can reduce costs, improve scalability, and support sustainability in low-volume protein therapy production.

What Happens When You Refuse To Compromise On Sustainability?

Discover how an empty building shell became a sustainable nanomedicine hub and achieved 47% energy savings and 88% fewer emissions, which sets new standards for innovation.

A Patient-Centric Approach To Streamline Pre-Screening Processes

Standardized condition questionnaires are now an essential infrastructure for connecting patients to clinical research, improving efficiency, and enhancing the overall patient experience.

The PXO Blueprint For Pediatric Clinical Trials

Address pediatric clinical trial challenges with a Patient Experience Optimization (PXO) model that follows four foundational layers that build confidence, drive trust, and ensure efficient enrollment.

Built Like A Tech Company: Why CROs Need A New Operating System

Modern research demands a tech-native operating model. Automation, continuous quality monitoring, and integrated systems are key to achieving predictable, scalable, and compliant bioanalysis.